Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
DNA Research
New DNA research study findings have been reported by scientists at Massachusetts Institute of Technology, Department of Chemical Engineering
April 8th, 2009
Scientists discuss in 'Engineering of bacterial strains and vectors for the production of plasmid DNA' new findings in dna research. According to recent research from the United States, "The demand for plasmid DNA (pDNA) is anticipated to increase significantly as DNA vaccines and non-viral gene therapies enter phase 3 clinical trials and are approved for use. This increased demand, along with renewed interest in pDNA as a therapeutic vector, has motivated research targeting the design of high-yield, cost-effective manufacturing processes." "An important aspect of this research is engineering bacterial strains and plasmids that are specifically suited to the production...
Source: Vaccine Weekly (2009-04-08)
|
